Regulations.gov document
Draft Guidance for Industry on Best Practices in Developing Proprietary Names for Drugs…
Notice · FDA-2014-D-0622 · posted Aug 14, 2014
Key facts
| Document ID | FDA-2014-D-0622-0006 |
|---|---|
| Title | Draft Guidance for Industry on Best Practices in Developing Proprietary Names for Drugs; Reopening of the Comment Period |
| Document type | Notice |
| Subtype | Extension of Comment Period |
| Agency | FDA |
| Docket | FDA-2014-D-0622 |
| Posted | Aug 14, 2014 |
| Federal Register citation | 79 FR 47654 |
| FR document number | 2014-19261 |
| Comment period opens | Aug 14, 2014 |
| Comments due | Sep 16, 2014 |
| Effective date | Aug 14, 2014 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: